Cite
MLA Citation
C. Touzeau et al.. “S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B-CELL MATURATION ANTIGEN (BCMA)-TARGETED AGENTS.” HemaSphere, vol. 6, n.d., pp. 85–86. http://access.bl.uk/ark:/81055/vdc_100158013726.0x000016